Health care utilization and cost associated with switching biologics within the first year of biologic treatment initiation among patients with ankylosing spondylitis

BACKGROUND: Costs associated with biologic switching and discontinuation can be high in chronic inflammatory diseases. Inappropriate use of medications may have cost implications for both payers and patients. Understanding of biologic utilization and switching rates is lacking among patients with an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Esther, Dai, Dong, Piao, Olivia W, Zheng, Josh Z, Park, Yujin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394190/
https://www.ncbi.nlm.nih.gov/pubmed/33043820
http://dx.doi.org/10.18553/jmcp.2020.19433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394190/
https://www.ncbi.nlm.nih.gov/pubmed/33043820
http://dx.doi.org/10.18553/jmcp.2020.19433

Ejemplares similares